PFM Health Sciences’s Endocyte, Inc. Common Stock ECYT Stock Holding History

PFM Health Sciences’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-234,378	Closed	-$4.16M	–	137
2018 Q3	$4.16M	Sell	234,378 -3,834,230	-94%	-$65.8M	0.06%	112
2018 Q2	$56.1M	Sell	4,068,608 -270,636	-6%	-$3.21M	0.88%	41
2018 Q1	$39.4M	Buy	4,339,244 +897,650	+26%	+$4.95M	0.8%	50
2017 Q4	$14.7M	Buy	+3,441,594	New	+$16.4M	0.35%	68

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

PFM Health Sciences's ECYT Position: Q4 2018 in Review

PFM Health Sciences sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 234,378 shares — an estimated $4.16M sold.

PFM Health Sciences first reported a position in ECYT in Q4 2017 and held it in 4 quarters. The position peaked at $56.1M in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

PFM Health Sciences reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
PFM Health Sciences sold 234,378 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $4.16M.
PFM Health Sciences first reported a position in Endocyte, Inc. Common Stock in Q4 2017 and held it in 4 quarters.
PFM Health Sciences's Endocyte, Inc. Common Stock position peaked at $56.1M in Q2 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.